Human papillomavirus vaccination for recalcitrant cutaneous warts

Emmanouil Karofylakis; Effrossyni Gkrania-Klotsas; Dinakantha Kumararatne

doi:10.1016/j.ijregi.2024.100488

Human papillomavirus vaccination for recalcitrant cutaneous warts

IJID Reg. 2024 Nov 10:13:100488. doi: 10.1016/j.ijregi.2024.100488. eCollection 2024 Dec.

Authors

Emmanouil Karofylakis¹, Effrossyni Gkrania-Klotsas¹, Dinakantha Kumararatne²

Affiliations

¹ Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
² Department of Immunology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Abstract

•Recalcitrant warts affect immunocompetent and immunocompromised persons.•The optimal approach to refractory warts remains unclear.•Human papillomavirus vaccination is a promising therapy for recalcitrant warts.

Keywords: Cutaneous warts; Human papillomavirus; Recalcitrant; Vaccine.